SLC5A2 and type 2 diabetes mellitus: Due to differences in dietary patterns or habits, body mass index, and genetic and racial backgrounds between Asian and non-Asian population [18], the effect on glycemic control and body weight control as well as the adverse effects of SGLT-2 inhibitors as an add-on treatment for metformin may be different between patients with T2DM in these two populations.